KEGG   DRUG: Daunorubicin and cytarabine
Entry
D11390            Mixture   Drug                                   
Name
Daunorubicin and cytarabine;
Vyxeos (TN)
Product
VYXEOS (Jazz Pharmaceuticals)
Component
(Daunorubicin [DR:D07776] | Daunorubicin hydrochloride [DR:D01264]), Cytarabine [DR:D00168]
Remark
Therapeutic category: 4291
ATC code: L01XY01
Product: D11390<JP/US>
Efficacy
Antineoplastic
  Disease
Acute myeloid leukemia [DS:H00003]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01X OTHER ANTINEOPLASTIC AGENTS
    L01XY Combinations of antineoplastic agents
     L01XY01 Cytarabine and daunorubicin
      D11390  Daunorubicin and cytarabine <JP/US>
USP drug classification [BR:br08302]
 Antineoplastics
  Antineoplastics, Other
   Daunorubicin/ Cytarabine
    D11390  Daunorubicin and cytarabine
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   429  Miscellaneous
    4291  Other Antitumors
     D11390  Daunorubicin and cytarabine
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11390
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11390
Other DBs
PubChem: 384585368

» Japanese version   » Back

  All links  
Ontology (5)   
   KEGG BRITE (5)   
Disease (1)   
   KEGG DISEASE (1)   
Chemical substance (1)   
   PubChem (1)   
All databases (7)   

Download RDF
DBGET integrated database retrieval system